Paul Mesburis

Paul Mesburis is a declared insider of Prometic Life Sciences Inc., with filings sourced from SEDI. The record holds 16 filings, for trades running from 5 January 2016 to 28 May 2019.

Market trades split into 3 purchases (€15k) and 7 sales (€43k). The net balance comes to €28k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises. So far in 2019, the count stands at 2 purchases and 6 sales.

A typical purchase (the median) is worth €4,503.

The record was last updated on 31 May 2019 with an open-market sale (€8,892) in Prometic Life Sciences Inc. The clock since the last published purchase (24 May 2019) now reads 2,711 days. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.